Search
for
Sort by
Research 451–480 of 1000+
- Upper gastrointestinal bleeding during the COVID-19 pandemic; particularities of diagnosis and therapy
- Dermatological Manifestations of COVID-19 in Children
- Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021
- Differentiated approach to the implementation of preventive and anti-epidemic measures among military personnel based on the COVID-19 disease risk assessment scale
- The most common pediatric and adult dermatology patient complaints in a month of the COVID‐19 pandemic in Turkey
- Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
- Characterization of Post-COVID-19 Clinical Manifestations Among Patients Visiting a Post-COVID-19 Clinic in a Tertiary Care Center: A Descriptive Study
- Taming of Covid-19: potential and emerging application of mesenchymal stem cells
- Diagnosis of hair disorders during the COVID‐19 pandemic: an introduction to teletrichoscopy
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Acute COVID-19 Syndrome Predicts Severe Long COVID-19: An Observational Study
- A study of COVID‐19 vaccine (Covishield) induced dermatological adverse effects from India
- Types and Characteristics of Hair Across the Globe: Results of a Multinational Study on 19,461 Individuals
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Long COVID-19 Effects (Chronic Covid-19 syndrome) in Nepalese Cohort recovered from SARS-CoV-2 infection
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity
- Differential risk for COVID-19 in the first wave of the disease (February-April 2020) among migrants from several areas of the world living in Alcorcón (Spain): A population-based cohort study
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
- Impacts of COVID-19 Pandemic on Dermatology Outpatient Department at a Tertiary Hospital in Eastern China: A Pre-Post Study
- Cognitive, emotional, physical, and behavioral stress-related symptoms and coping strategies among university students during the third wave of COVID-19 pandemic
- Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study
- Telecommunication in the COVID-19 era: As an assessment tool for patients with dermatomyositis
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Estimating long COVID-19 prevalence across definitions and forms of sample selection